Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features (original) (raw)

Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies

Bernadett Faragó

Clinical and experimental rheumatology

View PDFchevron_right

Association of Anti–Cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis

Tae-un Han

Arthritis & Rheumatism, 2007

View PDFchevron_right

THE DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES (anti-CCP) IN PATIENTS WITH RHEUMATOID ARTHRITIS DIJAGNOSTI^KO ZNA^ENJE ANTI-CIKLI^NIH CITRULINIRANIH PEPTIDNIH ANTITELA (anti-CCP) KOD PACIJENATA SA REUMATOIDNIM ARTRITISOM

Ljubinka Damjanovska

2007

View PDFchevron_right

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis

Rudolf Gruber

Annals of the Rheumatic Diseases, 2008

View PDFchevron_right

AB0284 The Diagnostic Utility of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis

Gehan A Hegazy

Annals of the Rheumatic Diseases, 2014

View PDFchevron_right

Diagnostic Value of Autoantibodies Against Citrullinated Peptide Antigens in Rheumatoid Arthritis: Comparison of Different Commercial Kits

Ozlem Şahin

Turkish Journal of Rheumatology, 2011

View PDFchevron_right

The Diagnostic Utility of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis

Gehan Hegazy

Egyptian Journal of Rheumatology and Clinical Immunology

View PDFchevron_right

Diagnostic Performance of Anti-Cyclic Citrullinated Peptide Antibodies in Rheumatoid Arthritis and Other Rheumatological Disorders

humberto ventura

International Journal of Current Microbiology and Applied Sciences, 2017

View PDFchevron_right

Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing

Mario Salazar-paramo, Arnulfo Hernán Nava-Zavala

BioMed Research International, 2014

View PDFchevron_right

Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis

Jacqueline Dekkers

Archives of Medical Science, 2011

View PDFchevron_right

Polymorphisms and functional haplotype in PADI4: Further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population

Salvador Muñoz Barrios

View PDFchevron_right

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

Cornelia der Zijde

Arthritis & Rheumatism, 2006

View PDFchevron_right

Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis

Per-johan Jakobsson

Arthritis & Rheumatism, 2013

View PDFchevron_right

Objective: To determine the usefulness of anti-Cyclic Citrullinated Peptide and anti-Mutated Citrullinated Vimentin antibody in the diagnosis of seronegative rheumatoid arthritis

bushra shah

2016

View PDFchevron_right

Shared Epitope and Anti-Cyclic Citrullinated Peptide Antibodies: Relationship with Age at Onset and Duration of Disease in Rheumatoid Arthritis

Benjamín Fernández-gutiérrez

The Journal of Rheumatology, 2009

View PDFchevron_right

Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis

Onelia Bistoni

Joint Bone Spine, 2017

View PDFchevron_right

Performance of Anti-Cyclic Citrullinated Peptide Assays Differs in Subjects at Increased Risk of Rheumatoid Arthritis and Subjects With Established Disease

Jan Hughes-austin

Arthritis & Rheumatism, 2013

View PDFchevron_right

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis

juan canete

Arthritis research & therapy, 2017

View PDFchevron_right

Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios

Donatello Pietrapertosa

Clinical Chemistry and Laboratory Medicine, 2010

View PDFchevron_right

Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis

Jane Ramberg

Annals of the Rheumatic Diseases, 2007

View PDFchevron_right

Spectrum of Anti Citrullinated Peptide Antibodies (ACPA) fine specificities is different between Malaysian and Swedish rheumatoid arthritis patients: Implications for pathogenesis of RA

Lars Alfredsson

Arthritis & rheumatology (Hoboken, N.J.), 2016

View PDFchevron_right

The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis

M. Cader, Karim Raza

BMC Musculoskeletal Disorders, 2010

View PDFchevron_right

Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis

Pooja Naik

Arthritis & Rheumatology, 2020

View PDFchevron_right

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

J. Avouac

Annals of the Rheumatic Diseases, 2005

View PDFchevron_right

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis

pooja naik

Frontiers in Immunology, 2018

View PDFchevron_right

Anti–Cyclic Citrullinated Peptide Antibodies in the Diagnosis of Rheumatoid Arthritis: Bayes Clears the Haze

matthew liang

Annals of Internal Medicine, 2007

View PDFchevron_right

Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis

Susan Bartlett

Arthritis & Rheumatism, 2008

View PDFchevron_right

Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis

Bardia Jamali

Rheumatology International, 2012

View PDFchevron_right

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients

Karin Lundberg

Arthritis & Rheumatism, 2010

View PDFchevron_right